Literature DB >> 9175692

Is it necessary to perform a prophylactic oophorectomy during hysterectomy?

Y Zalel1, S Lurie, Y Beyth, S Goldberger, R Tepper.   

Abstract

OBJECTIVE: To evaluate the subsequent pelvic sonographic characteristics as well as the clinical outcome following hysterectomy with and without oophorectomy. STUDY
DESIGN: A prospective study of sonographic evaluation of 164 women, aged 29-72 years, with a history of hysterectomy was performed. Ninety-one patients underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy and 73 women had either hysterectomy (abdominal or vaginal) only or hysterectomy with unilateral salpingo-oophorectomy.
RESULTS: The mean time interval between surgery and sonographic evaluation was 4.3 years (range, 1-25 years). Out of the 73 women with left ovaries, 37 (50.7%) were found to have pelvic lesions and four women underwent re-operations following these findings. The histologic finding were cystadenoma, hydrosalpinx with periovarian adhesions and two paraovarian cysts. In comparison, only five of the 91 women (5.5%) following bilateral salpingo-oophorectomy were found to have pelvic lesions (P < 0.0005). None of the women with prophylactic oophorectomy were operated upon following these findings.
CONCLUSIONS: In comparison to patients after total hysterectomy and bilateral salpingo-oophorectomy, women with prior hysterectomy and ovarian preservation are prone to subsequent pelvic lesions. They need to be closely followed with clinical, laboratory and sonographic means, and may undergo reoperations in order to rule out the possibility of neoplasia.

Entities:  

Mesh:

Year:  1997        PMID: 9175692     DOI: 10.1016/s0301-2115(97)02702-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.

Authors:  Sarah J Nyante; Amanda Black; Aimée R Kreimer; Máire A Duggan; J Daniel Carreon; Bruce Kessel; Saundra S Buys; Lawrence R Ragard; Karen A Johnson; Barbara K Dunn; Lois Lamerato; John M Commins; Christine D Berg; Mark E Sherman
Journal:  Gynecol Oncol       Date:  2010-12-07       Impact factor: 5.482

2.  Clinical analysis of high risk factors for pelvic malignant tumors after hysterectomy for benign diseases.

Authors:  Xiaopei Chao; Xiaoxia Wang; Yu Xiao; Mingliang Ji; Shu Wang; Honghui Shi; Qingbo Fan; Jinhua Leng; Dawei Sun; Jinghe Lang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

3.  Ovarian function and ovarian blood supply following premenopausal abdominal hysterectomy.

Authors:  Ibrahim A Abdelazim; Khaled M Abdelrazak; Assem A M Elbiaa; Mohamed M Farghali; Amr Essam; Gulmira Zhurabekova
Journal:  Prz Menopauzalny       Date:  2015-12-08

4.  Malignant risk of pelvic mass after hysterectomy for adenomyosis or endometriosis.

Authors:  Xiaopei Chao; Yang Liu; Mingliang Ji; Shu Wang; Honghui Shi; Qingbo Fan; Jinghe Lang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.